Citation: | ZHU Jiameng, SUN Longhe, SUN Qiannan, REN Jun, LIU Bin, WANG Liuhua, WANG Daorong. Regulatory role and mechanism of mitochondrial ribosomal protein S35 in proliferation, invasion, and migration of colon cancer cells[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 24-31,37. DOI: 10.7619/jcmp.20244162 |
To investigate the regulatory role and mechanism of mitochondrial ribosomal protein S35 (MRPS35) in the proliferation, invasion, and migration of colon cancer cells.
A total of 120 colon cancer tissues and adjacent normal tissues from patients undergoing radical resection for colon cancer were collected. Human colon cancer cell lines (HCT116, SW480, SW620) and a human normal colon epithelial cell line (NCM460) were cultured. Bioinformatics analysis, real-time quantitative polymerase chain reaction, Western blot, immunohistochemical (IHC) analysis, and cellular functional experiments (plate clone formation assay, scratch test, Transwell migration assay, CCK-8 cell viability assay) were conducted to evaluate the expression and regulatory mechanism of MRPS35 in colon cancer.
Bioinformatics analysis showed that the expression level of the MRPS35 gene was higher in colorectal cancer tissues than in adjacent normal tissues (P < 0.05). The relative expression levels of MRPS35 mRNA and MRPS35 protein were higher in human colon cancer cell lines (HCT116, SW480, SW620) than in NCM460 cells (P < 0.05). The relative expression level of MRPS35 protein was higher in colon cancer tissues than that in adjacent normal tissues (P < 0.05). The expression level of MRPS35 was significantly correlated with tumor diameter, tumor differentiation, and T stage (P=0.002, 0.021, 0.036). Patients with high MRPS35 expression had a higher overall survival rate than those with low MRPS35 expression (Log-rank P=0.015). After knockdown of MRPS35, the abilities of colon cancer cell cloning, proliferation, invasion, and migration were significantly enhanced. Furthermore, the expression of Wnt1, β-Catenin, and their downstream target proteins increased significantly after MRPS35 knockdown.
MRPS35 is significantly overexpressed in both colon cancer tissues and colon cancer cells, and it may inhibit the occurrence and development of colon cancer by regulating the Wnt/β-Catenin signaling pathway. Therefore, MRPS35 has the potential to become a novel biomarker and therapeutic target for colon cancer.
[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
[2] |
FIDLER M M, SOERJOMATARAM I, BRAY F. A global view on cancer incidence and national levels of the human development index[J]. Int J Cancer, 2016, 139(11): 2436-2446. doi: 10.1002/ijc.30382
|
[3] |
KOPPE M J, BOERMAN O C, OYEN W J, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies[J]. Ann Surg, 2006, 243(2): 212-222. doi: 10.1097/01.sla.0000197702.46394.16
|
[4] |
LIN X Y, GUO L J, LIN X, et al. Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer[J]. Sci Rep, 2022, 12: 10658. doi: 10.1038/s41598-022-14724-7
|
[5] |
LI X, WANG M, LI S, et al. HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia[J]. Theranostics, 2021, 11(15): 7337-7359. doi: 10.7150/thno.57804
|
[6] |
CHARAFE-JAUFFRET E, GINESTIER C, IOVINO F, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature[J]. Cancer Res, 2009, 69(4): 1302-1313. doi: 10.1158/0008-5472.CAN-08-2741
|
[7] |
SIEGEL R L, MILLER K D, GODING SAUER A, et al. Colorectal cancer statistics, 2020[J]. CA A Cancer J Clinicians, 2020, 70(3): 145-164. doi: 10.3322/caac.21601
|
[8] |
BAI Z, XIA X, LU J. microRNA-639 is down-regulated in hepatocellular carcinoma tumor tissue and inhibits proliferation and migration of human hepatocellular carcinoma cells through the KAT7/wnt/β-catenin pathway[J]. Med Sci Monit, 2020, 26: e919241.
|
[9] |
YUAN Y, JU Y S, KIM Y, et al. Comprehensive molecular characterization of mitochondrial genomes in human cancers[J]. Nat Genet, 2020, 52: 342-352. doi: 10.1038/s41588-019-0557-x
|
[10] |
3LIU L, LUO C, LUO Y, et al. MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression[J]. Oncogene, 2018, 37(1): 86-94. doi: 10.1038/onc.2017.314
|
[11] |
LEE Y K, LIM J J, JEOUN U W, et al. Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness[J]. J Biol Chem, 2017, 292(49): 20208-20217. doi: 10.1074/jbc.M117.809012
|
[12] |
TANG B, ZHU J, ZHAO Z, et al. Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden[J]. J Adv Res, 2021, 33: 153-165. doi: 10.1016/j.jare.2021.01.018
|
[13] |
黄灿坡, 王琳, 林建泉, 等. circMRPS35和KAT7在胃癌组织中的表达及预后评估价值[J]. 国际检验医学杂志, 2022, 43(23): 2846-2851.
|
[14] |
PU M, WANG J L, HUANG Q K, et al. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes[J]. Tumour Biol, 2017, 39(7): 101042831770912.
|
[15] |
WANG X, PERALTA S, MORAES C T. Mitochondrial alterations during carcinogenesis: a review of metabolic transformation and targets for anticancer treatments[J]. Adv Cancer Res, 2013, 119: 127-160.
|
[16] |
PIAO L, LI Y, KIM S J, et al. Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death[J]. Cancer Res, 2009, 69(8): 3397-3404. doi: 10.1158/0008-5472.CAN-08-3235
|
[17] |
CHEN Y C, CHANG M Y, SHIAU A L, et al. Mitochondrial ribosomal protein S36 delays cell cycle progression in association with p53 modification and p21(WAF1/CIP1) expression[J]. J Cell Biochem, 2007, 100(4): 981-990. doi: 10.1002/jcb.21079
|
[18] |
YOO Y A, KIM M J, PARK J K, et al. Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1[J]. Mol Cell Biol, 2005, 25(15): 6603-6616. doi: 10.1128/MCB.25.15.6603-6616.2005
|
[19] |
TANIUE K, HAYASHI T, KAMOSHIDA Y, et al. UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells[J]. Oncogene, 2020, 39: 1018-1030. doi: 10.1038/s41388-019-1032-y
|
[20] |
CLEVERS H. Wnt/beta-catenin signaling in development and disease[J]. Cell, 2006, 127(3): 469-480. doi: 10.1016/j.cell.2006.10.018
|
[21] |
KRAUSOVA M, KORINEK V. Wnt signaling in adult intestinal stem cells and cancer[J]. Cell Signal, 2014, 26(3): 570-579.
|